Mechanisms of disease: The human N-glycome

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 8, 2016, Pages 1574-1582

  Lauc, Gordan ^a,b   Pezer, Marija ^b   Rudan, Igor ^c   Campbell, Harry ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Glycosylation in disease; Human glycome; IgG glycosylation; Protein glycosylation

Indexed keywords

GLYCAN; GLYCOPROTEIN; GLYCOPROTEOME; HEPARIN; HYALURONIC ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; N GLYCAN; N GLYCOME; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OBINUTUZUMAB; OSELTAMIVIR; PROTEOME; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ZANAMIVIR; POLYSACCHARIDE;

ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; COMMENSAL; DRUG EFFICACY; GLYCOSYLATION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; GENETICS; HUMAN GENOME; METABOLIC DISEASES; METABOLISM; PERSONALIZED MEDICINE; PROCEDURES;

GENOME, HUMAN; HUMANS; METABOLIC DISEASES; POLYSACCHARIDES; PRECISION MEDICINE;

EID: 84973652541     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.10.016     Document Type: Article

References (100)

1. D. Walt, K.F. Aoki-Kinoshita, B. Bendiak, C.R. Bertozzi, G.J. Boons, A. Darvill, G. Hart, L.L. Kiessling, J. Lowe, R. Moon, J. Paulson, R. Sasisekharan, A. Varki, and C.H. Wong Transforming Glycoscience: A Roadmap for the Future 2012 National Academies Press Washington
2. K.W. Marek, I.K. Vijay, and J.D. Marth A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality Glycobiology 9 1999 1263 1271
3. European-Glycoscience-Forum, Roadmap for Glycoscience in Europe http://www.ibcarb.com/glycoscienceroadmap/index.html 2015
4. R. Apweiler, H. Hermjakob, and N. Sharon On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database Biochim. Biophys. Acta 1473 1999 4 8
5. K.W. Moremen, M. Tiemeyer, and A.V. Nairn Vertebrate protein glycosylation: diversity, synthesis and function Nat. Rev. Mol. Cell Biol. 13 2012 448 462
6. K. Ohtsubo, and J.D. Marth Glycosylation in cellular mechanisms of health and disease Cell 126 2006 855 867
7. A. Knežević, O. Gornik, O. Polašek, M. Pučić, M. Novokmet, I. Redžić, P.M. Rudd, A.F. Wright, H. Campbell, I. Rudan, and G. Lauc Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans Glycobiology 20 2010 959 969
8. G. Lauc, and V. Zoldoš Protein glycosylation - an evolutionary crossroad between genes and environment Mol. BioSyst. 6 2010 2373 2379
9. G. Lauc, A. Vojta, and V. Zoldos Epigenetic regulation of glycosylation is the quantum mechanics of biology Biochim. Biophys. Acta 1840 2014 65 70
10. H.H. Freeze Genetic defects in the human glycome Nat. Rev. Genet. 7 2006 537 551
11. M.M. Fuster, and J.D. Esko The sweet and sour of cancer: glycans as novel therapeutic targets Nat. Rev. Cancer 5 2005 526 542
12. N. Taniguchi, and Y. Kizuka Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics Adv. Cancer Res. 2015 (in press)
13. D.H. Dube, and C.R. Bertozzi Glycans in cancer and inflammation - potential for therapeutics and diagnostics Nat. Rev. Drug Discov. 4 2005 477 488
14. S. Yamada, Y. Suzuki, T. Suzuki, M.Q. Le, C.A. Nidom, Y. Sakai-Tagawa, Y. Muramoto, M. Ito, M. Kiso, T. Horimoto, K. Shinya, T. Sawada, M. Kiso, T. Usui, T. Murata, Y.P. Lin, A. Hay, L.F. Haire, D.J. Stevens, R.J. Russell, S.J. Gamblin, J.J. Skehel, and Y. Kawaoka Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors Nature 444 2006 378 382
15. L. Hu, S.E. Crawford, R. Czako, N.W. Cortes-Penfield, D.F. Smith, J. Le Pendu, M.K. Estes, and B.V. Prasad Cell attachment protein VP8∗of a human rotavirus specifically interacts with A-type histo-blood group antigen Nature 485 2012 256 259
16. D. Ilver, A. Arnqvist, J. Ogren, I.M. Frick, D. Kersulyte, E.T. Incecik, D.E. Berg, A. Covacci, L. Engstrand, and T. Boren Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging Science 279 1998 373 377
17. R.I. Glass, U.D. Parashar, and M.K. Estes Norovirus gastroenteritis N. Engl. J. Med. 361 2009 1776 1785
18. M. Cohen, N. Hurtado-Ziola, and A. Varki ABO blood group glycans modulate sialic acid recognition on erythrocytes Blood 114 2009 3668 3676
19. D.S. Newburg, G.M. Ruiz-Palacios, and A.L. Morrow Human milk glycans protect infants against enteric pathogens Annu. Rev. Nutr. 25 2005 37 58
20. H. Nothaft, and C.M. Szymanski Protein glycosylation in bacteria: sweeter than ever Nat. Rev. Microbiol. 8 2010 765 778
21. C.M. Fletcher, M.J. Coyne, O.F. Villa, M. Chatzidaki-Livanis, and L.E. Comstock A general O-glycosylation system important to the physiology of a major human intestinal symbiont Cell 137 2009 321 331
22. L.V. Hooper, T. Midtvedt, and J.I. Gordon How host-microbial interactions shape the nutrient environment of the mammalian intestine Annu. Rev. Nutr. 22 2002 283 307
23. A.R. Pacheco, M.M. Curtis, J.M. Ritchie, D. Munera, M.K. Waldor, C.G. Moreira, and V. Sperandio Fucose sensing regulates bacterial intestinal colonization Nature 492 2012 113 117
24. L.A. Lasky Selectins: interpreters of cell-specific carbohydrate information during inflammation Science 258 1992 964 969
25. L.A. Lasky Selectin-carbohydrate interactions and the initiation of the inflammatory response Annu. Rev. Biochem. 64 1995 113 139
26. F. Austrup, D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues Nature 385 1997 81 83
27. J. Mitoma, X. Bao, B. Petryanik, P. Schaerli, J.M. Gauguet, S.Y. Yu, H. Kawashima, H. Saito, K. Ohtsubo, J.D. Marth, K.H. Khoo, U.H. von Andrian, J.B. Lowe, and M. Fukuda Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment Nat. Immunol. 8 2007 409 418
28. C.A.S. Hill Interactions between endothelial selectins and cancer cells regulate metastasis Frontiers in Bioscience-Landmark 16 2011 3233 3251
29. O.D. Genbacev, A. Prakobphol, R.A. Foulk, A.R. Krtolica, D. Ilic, M.S. Singer, Z.Q. Yang, L.L. Kiessling, S.D. Rosen, and S.J. Fisher Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface Science 299 2003 405 408
30. K. Ley The role of selectins in inflammation and disease Trends Mol. Med. 9 2003 263 268
31. D.D. Wagner, and P.S. Frenette The vessel wall and its interactions Blood 111 2008 5271 5281
32. P.W. Bedard, and N. Kaila Selectin inhibitors: a patent review Expert Opin. Ther. Pat. 20 2010 781 793
33. J.W. Homeister, A.D. Thall, B. Petryniak, P. Maly, C.E. Rogers, P.L. Smith, R.J. Kelly, K.M. Gersten, S.W. Askari, G.Y. Cheng, G. Smithson, R.M. Marks, A.K. Misra, O. Hindsgaul, U.H. von Andrian, and J.B. Lowe The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing Immunity 15 2001 115 126
34. P.L. Smith, J.T. Myers, C.E. Rogers, L. Zhou, B. Petryniak, D.J. Becker, J.W. Homeister, and J.B. Lowe Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus J. Cell Biol. 158 2002 801 815
35. A. Etzioni, M. Frydman, S. Pollack, I. Avidor, M.L. Phillips, J.C. Paulson, and R. Gershoni-Baruch Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency N. Engl. J. Med. 327 1992 1789 1792
36. J.W. Dennis, I.R. Nabi, and M. Demetriou Metabolism, cell surface organization, and disease Cell 139 2009 1229 1241
37. A. Knežević, O. Polašek, O. Gornik, I. Rudan, H. Campbell, C. Hayward, A. Wright, I. Kolčić, N. O'Donoghue, J. Bones, P.M. Rudd, and G. Lauc Variability, heritability and environmental determinants of human plasma N-glycome J. Proteome Res. 8 2009 694 701
38. M. Pučić, S. Pinto, M. Novokmet, A. Knežević, O. Gornik, O. Polašek, K. Vlahoviček, W. Wei, P.M. Rudd, A.F. Wright, H. Campbell, I. Rudan, and G. Lauc Common aberrations from normal human N-glycan plasma profile Glycobiology 20 2010 970 975
39. P.M. Rudd, T. Elliott, P. Cresswell, I.A. Wilson, and R.A. Dwek Glycosylation and the immune system Science 291 2001 2370 2376
40. I. Schwab, and F. Nimmerjahn Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat. Rev. Immunol. 13 2013 176 189
41. M. Pucic, A. Knezevic, J. Vidic, B. Adamczyk, M. Novokmet, O. Polasek, O. Gornik, S. Supraha-Goreta, M.R. Wormald, I. Redzic, H. Campbell, A. Wright, N.D. Hastie, J.F. Wilson, I. Rudan, M. Wuhrer, P.M. Rudd, D. Josic, and G. Lauc High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations Mol. Cell. Proteomics 10 2011 M111 010090
42. O. Gornik, J. Wagner, M. Pučić, A. Knežević, I. Redžić, and G. Lauc Stability of N-glycan profiles in human plasma Glycobiology 19 2009 1547 1553
43. J. Kristic, F. Vuckovic, C. Menni, L. Klaric, T. Keser, I. Beceheli, M. Pucic-Bakovic, M. Novokmet, M. Mangino, K. Thaqi, P. Rudan, N. Novokmet, J. Sarac, S. Missoni, I. Kolcic, O. Polasek, I. Rudan, H. Campbell, C. Hayward, Y. Aulchenko, A. Valdes, J.F. Wilson, O. Gornik, D. Primorac, V. Zoldos, T. Spector, and G. Lauc Glycans are a novel biomarker of chronological and biological ages J. Gerontol. A Biol. Sci. Med. Sci. 69 2014 779 789
44. M. Novokmet, E. Lukic, F. Vuckovic, Z. Duric, T. Keser, K. Rajsl, D. Remondini, G. Castellani, H. Gasparovic, O. Gornik, and G. Lauc Changes in IgG and total plasma protein glycomes in acute systemic inflammation Sci. Rep. 4 2014 4347
45. S. Iida, H. Misaka, M. Inoue, M. Shibata, R. Nakano, N. Yamane-Ohnuki, M. Wakitani, K. Yano, K. Shitara, and M. Satoh Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa Clin. Cancer Res. 12 2006 2879 2887
46. K. Masuda, T. Kubota, E. Kaneko, S. Iida, M. Wakitani, Y. Kobayashi-Natsume, A. Kubota, K. Shitara, and K. Nakamura Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity Mol. Immunol. 44 2007 3122 3131
47. R. Niwa, S. Hatanaka, E. Shoji-Hosaka, M. Sakurada, Y. Kobayashi, A. Uehara, H. Yokoi, K. Nakamura, and K. Shitara Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 is independent of FcgammaRIIIa functional polymorphism Clin. Cancer Res. 10 2004 6248 6255
48. C.N. Scanlan, D.R. Burton, and R.A. Dwek Making autoantibodies safe Proc. Natl. Acad. Sci. U. S. A. 105 2008 4081 4082
49. T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-Hosaka, Y. Kanda, M. Sakurada, K. Uchida, H. Anazawa, M. Satoh, M. Yamasaki, N. Hanai, and K. Shitara The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity J. Biol. Chem. 278 2003 3466 3473
50. S. Preithner, S. Elm, S. Lippold, M. Locher, A. Wolf, A.J. da Silva, P.A. Baeuerle, and N.S. Prang High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G Mol. Immunol. 43 2006 1183 1193
51. C. Ferrara, S. Grau, C. Jager, P. Sondermann, P. Brunker, I. Waldhauer, M. Hennig, A. Ruf, A.C. Rufer, M. Stihle, P. Umana, and J. Benz Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose Proc. Natl. Acad. Sci. U. S. A. 108 2011 12669 12674
52. C. Ferrara, F. Stuart, P. Sondermann, P. Brunker, and P. Umana The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms J. Biol. Chem. 281 2006 5032 5036
53. C.M. Karsten, M.K. Pandey, J. Figge, R. Kilchenstein, P.R. Taylor, M. Rosas, J.U. McDonald, S.J. Orr, M. Berger, D. Petzold, V. Blanchard, A. Winkler, C. Hess, D.M. Reid, I.V. Majoul, R.T. Strait, N.L. Harris, G. Kohl, E. Wex, R. Ludwig, D. Zillikens, F. Nimmerjahn, F.D. Finkelman, G.D. Brown, M. Ehlers, and J. Kohl Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1 Nat. Med. 18 2012 1401 1406
54. R. Malhotra, M.R. Wormald, P.M. Rudd, P.B. Fischer, R.A. Dwek, and R.B. Sim Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein Nat. Med. 1 1995 237 243
55. S. Mihai, and F. Nimmerjahn The role of Fc receptors and complement in autoimmunity Autoimmun. Rev. 2012
56. Y. Kaneko, F. Nimmerjahn, and J.V. Ravetch Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science 313 2006 670 673
57. A. Samuelsson, T.L. Towers, and J.V. Ravetch Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor Science 291 2001 484 486
58. F. Nimmerjahn, and J.V. Ravetch Fcgamma receptors as regulators of immune responses Nat. Rev. Immunol. 8 2008 34 47
59. A. Davidson, and B. Diamond Autoimmune diseases N. Engl. J. Med. 345 2001 340 350
60. H. Albert, M. Collin, D. Dudziak, J.V. Ravetch, and F. Nimmerjahn In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner Proc. Natl. Acad. Sci. U. S. A. 105 2008 15005 15009
61. L. Baudino, S. Azeredo da Silveira, M. Nakata, and S. Izui Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies Springer Semin. Immunopathol. 28 2006 175 184
62. R.B. Parekh, R.A. Dwek, B.J. Sutton, D.L. Fernandes, A. Leung, D. Stanworth, T.W. Rademacher, T. Mizuochi, T. Taniguchi, and K. Matsuta Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG Nature 316 1985 452 457
63. R.B. Parekh, I.M. Roitt, D.A. Isenberg, R.A. Dwek, B.M. Ansell, and T.W. Rademacher Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity Lancet 1 1988 966 969
64. A. Ercan, J. Cui, D.E. Chatterton, K.D. Deane, M.M. Hazen, W. Brintnell, C.I. O'Donnell, L.A. Derber, M.E. Weinblatt, N.A. Shadick, D.A. Bell, E. Cairns, D.H. Solomon, V.M. Holers, P.M. Rudd, and D.M. Lee Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis Arthritis Rheum. 62 2010 2239 2248
65. Y. Rombouts, E. Ewing, L.A. van de Stadt, M.H. Selman, L.A. Trouw, A.M. Deelder, T.W. Huizinga, M. Wuhrer, D. van Schaardenburg, R.E. Toes, and H.U. Scherer Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis Ann. Rheum. Dis. 2013
66. I. Trbojević Akmačić, N.T. Ventham, E. Theodoratou, F. Vučković, N.A. Kennedy, J. Krištić, E.R. Nimmo, R. Kalla, H. Drummond, J. Štambuk, M.G. Dunlop, M. Novokmet, Y. Aulchenko, O. Gornik, H. Campbell, M. Pučić Baković, J. Satsangi, G. Lauc, and I.-B. Consortium Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin g glycome Inflamm. Bowel Dis. 21 2015 1237 1247
67. M.F. Go, R.E. Schrohenloher, and M. Tomana Deficient galactosylation of serum IgG in inflammatory bowel disease: correlation with disease activity J. Clin. Gastroenterol. 18 1994 86 87
68. F. Vučković, J. Krištić, I. Gudelj, M.T. Artacho, T. Keser, M. Pezer, M. Pučić-Baković, J. Štambuk, I. Trbojević-Akmačić, C. Barrios, T. Pavić, C. Menni, Y. Wang, Y. Zhou, L. Cui, H. Song, Q. Zeng, X. Guo, B. Pons-Estel, P. McKeigue, A.L. Patrick, O. Gornik, T.D. Spector, M. Harjaček, M.E. Alarcon-Riquelme, M. Molokhia, W. Wang, and G. Lauc Systemic lupus erythematosus associates with the decreased immunosuppressive potential of the IgG glycome Arthritis & Rheumatology 2015 (published online)
69. M. Tomana, R.E. Schrohenloher, J.D. Reveille, F.C. Arnett, and W.J. Koopman Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases Rheumatol. Int. 12 1992 191 194
70. C. Menni, T. Keser, M. Mangino, J.T. Bell, I. Erte, I. Akmačić, F. Vučković, M. Pučić-Baković, O. Gornik, M.I. McCarthy, V. Zoldoš, T.D. Spector, G. Lauc, and A. Valdes Glycosylation of immunoglobulin G: role of genetic and epigenetic influences PLoS One 8 2013 e82558
71. A. Antonopoulos, S.J. North, S.M. Haslam, and A. Dell Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses Biochem. Soc. Trans. 39 2011 1334 1340
72. M. Demetriou, M. Granovsky, S. Quaggin, and J.W. Dennis Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation Nature 409 2001 733 739
73. S. Pillai, A. Cariappa, and S.P. Pirnie Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance Trends Immunol. 30 2009 488 493
74. I. Surolia, S.P. Pirnie, V. Chellappa, K.N. Taylor, A. Cariappa, J. Moya, H. Liu, D.W. Bell, D.R. Driscoll, S. Diederichs, K. Haider, I. Netravali, S. Le, R. Elia, E. Dow, A. Lee, J. Freudenberg, P.L. De Jager, Y. Chretien, A. Varki, M.E. MacDonald, T. Gillis, T.W. Behrens, D. Bloch, D. Collier, J. Korzenik, D.K. Podolsky, D. Hafler, M. Murali, B. Sands, J.H. Stone, P.K. Gregersen, and S. Pillai Functionally defective germline variants of sialic acid acetylesterase in autoimmunity Nature 466 2010 243 U118
75. J. Krištić, V. Zoldoš, and G. Lauc Complex genetics of protein N-glycosylation T. Endo, P.H. Seeberger, G.W. Hart, C.-H. Wong, N. Taniguchi, Glycoscience: Biology and Medicine 2014 Springer Japan 1 7
76. O. Gornik, T. Pavic, and G. Lauc Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease Biochim. Biophys. Acta 1820 2012 1318 1326
77. P.D. Bos, X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massague Genes that mediate breast cancer metastasis to the brain Nature 459 2009 1005 1009
78. P.M. Drake, W. Cho, B. Li, A. Prakobphol, E. Johansen, N.L. Anderson, F.E. Regnier, B.W. Gibson, and S.J. Fisher Sweetening the pot: adding glycosylation to the biomarker discovery equation Clin. Chem. 56 2010 223 236
79. D.L. Meany, and D.W. Chan Aberrant glycosylation associated with enzymes as cancer biomarkers Clin. Proteomics 8 2011 7
80. V. Padler-Karavani Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine Cancer Lett. 352 2014 102 112
81. T. Lange, T.R. Samatov, A.G. Tonevitsky, and U. Schumacher Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells Carbohydr. Res. 389 2014 39 45
82. L. Freire-de-Lima Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition Frontiers in oncology 4 2014 59
83. S.S. Pinho, S. Carvalho, R. Marcos-Pinto, A. Magalhaes, C. Oliveira, J. Gu, M. Dinis-Ribeiro, F. Carneiro, R. Seruca, and C.A. Reis Gastric cancer: adding glycosylation to the equation Trends Mol. Med. 19 2013 664 676
84. S. Gilgunn, P.J. Conroy, R. Saldova, P.M. Rudd, and R.J. O'Kennedy Aberrant PSA glycosylation - a sweet predictor of prostate cancer Nat. Rev. Urol. 10 2013 99 107
85. F. Dall'Olio, N. Malagolini, M. Trinchera, and M. Chiricolo Mechanisms of cancer-associated glycosylation changes Front. Biosci. 17 2012 670 699
86. D. Ghaderi, R.E. Taylor, V. Padler-Karavani, S. Diaz, and A. Varki Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins Nat. Biotechnol. 28 2010 863 U145
87. J. Golay, F. Da Roit, L. Bologna, C. Ferrara, J.H. Leusen, A. Rambaldi, C. Klein, and M. Introna Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab Blood 122 2013 3482 3491
88. J.C. Egrie, and J.K. Browne Development and characterization of novel erythropoiesis stimulating protein (NESP) Br. J. Cancer 84 Suppl 1 2001 3 10
89. H.F. Bunn Erythropoietin Cold Spring Harbor perspectives in medicine 3 2013 a011619
90. A. Moscona Drug therapy - neuraminidase inhibitors for influenza N. Engl. J. Med. 353 2005 1363 1373
91. N. Washburn, I. Schwab, D. Ortiz, N. Bhatnagar, J.C. Lansing, A. Medeiros, S. Tyler, D. Mekala, E. Cochran, H. Sarvaiya, K. Garofalo, R. Meccariello, J.W. Meador III, L. Rutitzky, B.C. Schultes, L. Ling, W. Avery, F. Nimmerjahn, A.M. Manning, G.V. Kaundinya, and C.J. Bosques Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity Proc. Natl. Acad. Sci. U. S. A. 2015
92. J.W. Dennis, K.S. Lau, M. Demetriou, and I.R. Nabi Adaptive regulation at the cell surface by N-glycosylation Traffic 10 2009 1569 1578
93. K. Ohtsubo, S. Takamatsu, M.T. Minowa, A. Yoshida, M. Takeuchi, and J.D. Marth Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes Cell 123 2005 1307 1321
94. E.A. Partridge, C. Le Roy, G.M. Di Guglielmo, J. Pawling, P. Cheung, M. Granovsky, I.R. Nabi, J.L. Wrana, and J.W. Dennis Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis Science 306 2004 120 124
95. H. Schachter The search for glycan function: fucosylation of the TGF-beta1 receptor is required for receptor activation Proc. Natl. Acad. Sci. U. S. A. 102 2005 15721 15722
96. Y.C. Liu, H.Y. Yen, C.Y. Chen, C.H. Chen, P.F. Cheng, Y.H. Juan, K.H. Khoo, C.J. Yu, P.C. Yang, T.L. Hsu, and C.H. Wong Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells Proc. Natl. Acad. Sci. U. S. A. 108 2011 11332 11337
97. W.Y. Lo, A.H. Lagrange, C.C. Hernandez, R. Harrison, A. Dell, S.M. Haslam, J.H. Sheehan, and R.L. Macdonald Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating J. Biol. Chem. 285 2010 31348 31361
98. S. Ogata, C. Shimizu, A. Franco, R. Touma, J.T. Kanegaye, B.P. Choudhury, N.N. Naidu, Y. Kanda, L.T. Hoang, M.L. Hibberd, A.H. Tremoulet, A. Varki, and J.C. Burns Treatment response in kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin g PLoS One 8 2013 e81448
99. M.E. Ackerman, M. Crispin, X. Yu, K. Baruah, A.W. Boesch, D.J. Harvey, A.S. Dugast, E.L. Heizen, A. Ercan, I. Choi, H. Streeck, P.A. Nigrovic, C. Bailey-Kellogg, C. Scanlan, and G. Alter Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity J. Clin. Invest. 123 2013 2183 2192
100. V. Zoldos, T. Horvat, and G. Lauc Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies Curr. Opin. Chem. Biol. 17 2013 34 40